Human recombinant B7-H3 (4Ig) (from HEK293)
- Conjugation:Unconjugated
- Protein/peptide type:Recombinant
- Source:HEK293 cells
- Species:Human
- Storage conditions:–20 °C
- Endotoxin content:Less than 1,0 EU per μg by the LAL method.
- Biological activity:Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human B7-H3 (4Ig), His Tag at 2 μg/ml (100 μl/well) can bind Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 with a linear range of 0,3-5 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilised Monoclonal Anti-Human B7-H3 / B7-H3 (4Ig) Antibody, Human IgG1 at 2 μg/ml (100 μl/well) can bind Human B7-H3 (4Ig), His Tag with a linear range of 1-10 ng/ml (Routinely tested).; Human B7-H3 (4Ig), His Tag inhibits Anti-CD3-induced proliferation of PBMC. The EC50 for this effect is 7,95 μg/ml (Routinely tested)
- Gene ID:Q5ZPR3-1
- Carrier-free:Y
- Protease-free:Y
- Animal-free:Y
- Protein synonyms:B7 homolog 3|B7-H3|UNQ309/PRO352|4Ig-B7-H3|PSEC0249|CD276
- Protein/peptide name:B7-H3 (4Ig)
- Purity:>95%
- Molecular weight:48,5 kDa
- Endotoxin level:Low
- Formulation:Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation
- Nuclease-free:Y
- Shipping temperature:Powder,RT
Frequently Bought Together